Carbonate-Bearing Ionizable Lipids for mRNA Delivery to Splenic NK Cells
Journal of the American Chemical Society · 13.08.2025 · 147 (32) · 28665-28673
DOI: 10.1021/jacs.5c01389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 11.06.2025. Verfasst von Shiqi Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center of the Second Affiliated Hospital of Zhejiang University School of Medicine, College of Pharmaceutical Sciences, Liangzhu Laboratory, Zhej…. Hauptthemen laut MEDLINE: Killer Cells, Natural, RNA, Messenger, Spleen, Lipids. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
mRNA immunotherapies targeting natural killer (NK) cells hold substantial potential for treating cancer and viral diseases. However, achieving functional delivery of mRNA to splenic NK cell subsets remains a formidable challenge. Herein, we rationally design a library of 161 carbonate-bearing ionizable lipids (CAILs) and formulate lipid nanoparticles (LNPs) for functional mRNA delivery to the spleen and NK cells following intravenous administration. Unlike traditional LNPs that primarily target the liver, CAIL-based four-component LNPs predominantly deliver mRNA to the spleen. Notably, the removal of cholesterol from CAIL LNPs further enhances the spleen-targeting specificity and efficacy, significantly surpassing those of previous spleen-targeted LNPs. As a result, the optimized CAIL LNPs achieve robust mRNA translation in splenic NK cells, inducing encouraging transfection of 21% of splenic NK cells in an Ai9 mouse model. The lipid structural design and LNP formulation optimization pave the way to address the challenge of efficient mRNA delivery to NK cells, presenting opportunities for the development of NK cell-based mRNA therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Eye Center of the Second Affiliated Hospital of Zhejiang University School of Medicine, College of Pharmaceutical Sciences, Liangzhu Laboratory, Zhejiang University, Hangzhou 310058, China.
- State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
- Zhejiang Key Laboratory of Pain Perception and Neuromodulation, Hangzhou 310009, China.
ORCID-Profile: Shuai Liu
Förderung
- China Postdoctoral Science Foundation
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Zhejiang Provincial Natural Science Foundation of China
- Startup Package of Zhejiang University
- National Natural Science Foundation of China
Zitieren
APA
Wu, S., Shi, L., Su, K., Lin, L., Yan, X., Zhang, Y., Gu, T., Wang, Z., Xu, T., & Liu, S. (2025). Carbonate-Bearing Ionizable Lipids for mRNA Delivery to Splenic NK Cells. Journal of the American Chemical Society, 147(32), 28665-28673. https://doi.org/10.1021/jacs.5c01389
Vancouver
Wu S, Shi L, Su K, Lin L, Yan X, Zhang Y, et al. Carbonate-Bearing Ionizable Lipids for mRNA Delivery to Splenic NK Cells. Journal of the American Chemical Society. 2025;147(32):28665-28673. doi:10.1021/jacs.5c01389
BibTeX
@article{Wu2025,
author = {Wu, Shiqi and Shi, Lu and Su, Kexin and Lin, Lixin and Yan, Xinxin and Zhang, Yiran and Gu, Tianrui and Wang, Zichuan and Xu, Tengfei and Liu, Shuai},
title = {Carbonate-Bearing Ionizable Lipids for mRNA Delivery to Splenic NK Cells},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {32},
pages = {28665--28673},
doi = {10.1021/jacs.5c01389}
}
EUVIMED